Agios' Pyrukynd met primary endpoint in Phase 3 study for children with PK deficiency who don't need regular transfusions, ...
The Senate on Thursday confirmed Robert F. Kennedy Jr. as secretary of Health and Human Services, putting a longtime ...
In a surprise move Thursday, Neumora remade its executive team and brought back its former CEO, following last month's ...
Sanofi faces $250M charge after E. coli vaccine developed with J&J fails Phase 3 trial; study ends early due to insufficient ...
Idorsia’s plan to hand over the global rights to its blood pressure drug Tryvio has ended in disappointment after a deal announced in November fell through.
An NIH cap on indirect cost payments for grant recipients is casting a shroud of uncertainty for research universities ...
New research from the University of North Carolina-Chapel Hill found that Novo Nordisk’s weight loss drug may help ...
Pfizer secured an eighth indication for its blood cancer drug Adcetris after the FDA approved its use in adults, in ...
Newleos Therapeutics emerged Thursday with $93.5 million and a bundle of oral small molecules that it licensed from Roche, further demonstrating that the pharma-to-startup pipeline for CNS drugs is ...
Cerula Care raises $3.7M seed round to support cancer patients' mental health between appointments, selling directly to ...
After quickly enrolling its pivotal trial and recruiting more patients with a rare muscle disease than anticipated, Abcuro ...
CMO Dietmar Berger leads Gilead's R&D efforts with 54 clinical programs, anticipating Sunlenca's HIV PrEP launch & touting no ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback